1. Home
  2. WBX vs STRO Comparison

WBX vs STRO Comparison

Compare WBX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$2.37

Market Cap

118.0M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$11.59

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
STRO
Founded
2015
2003
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
85.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WBX
STRO
Price
$2.37
$11.59
Analyst Decision
Buy
Hold
Analyst Count
4
8
Target Price
$9.00
$18.29
AVG Volume (30 Days)
33.3K
120.7K
Earning Date
02-26-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$174,593,453.00
$105,646,000.00
Revenue This Year
N/A
$63.08
Revenue Next Year
$37.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$5.23
52 Week High
$14.40
$21.50

Technical Indicators

Market Signals
Indicator
WBX
STRO
Relative Strength Index (RSI) 24.77 79.96
Support Level $2.49 $8.49
Resistance Level $3.36 $12.00
Average True Range (ATR) 0.20 0.84
MACD -0.02 -0.05
Stochastic Oscillator 6.13 84.03

Price Performance

Historical Comparison
WBX
STRO

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: